查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375885

预防性医疗保健技术和服务市场规模、份额和趋势分析报告：2023-2030 年按类型、地区和细分市场分類的趋势

Preventive Healthcare Technologies And Services Market Size, Share & Trends Analysis Report By Type (Early Detection & Screening, Chronic Disease Management, Vaccines), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

预防保健技术和服务市场成长和趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球预防保健技术和服务市场规模预计将达到5,856亿美元，2023年至2030年年复合成长率为11.8%。

推动市场扩张的关键因素是人们对预防措施的认识不断增强，这些措施可以提高生活品质、延长寿命并最大限度地减少医疗支出。

该市场的成长得益于先进技术的采用以及疫苗、筛检和监测设备以及智慧设备等预防措施的发展，以减少医疗错误。此外，出生率下降导致老年人口增加，老年人口更容易患慢性病，这也支持了市场成长。

自2010年以来，各国引入人类发展指数（HDI）评估，关注本国和人民的整体发展。预期寿命对 HDI 计算有重大影响。各国政府正在努力透过实施各种计划来提高人口的预期寿命，包括免费或负担得起的免疫接种、戒烟和负担得起的健康保险。这些计划对可预防的技术和服务领域产生直接的正面影响。

预防性医疗保健的很大一部分涉及早期检测和筛检技术。该领域与个体化诊断技术相关，并且由于诊断准确性和创新技术的可用性而获得最大份额。

预防性医疗技术和服务市场报告亮点：

  • 根据世界卫生组织发布的资料，美国的疫苗接种比例正在上升。疫苗接种包括政府资助的疫苗和私人购买的疫苗。
  • 2022年，早期检测和筛检技术领域将占据最大份额。个人化医疗技术的相关优势，例如高精度和早期发现可能的疾病和失调，是该领域最大份额的主要驱动力。
  • 由于先进技术的引入和对准确筛检方法的需求不断增长，早期检测和筛检预计将在预测期内出现最快的增长。
  • 北美地区在 2022 年以 40.4% 的最大收益占有率主导市场。
  • 经济成长和政府配合措施预计将推动亚太地区的成长。预计该领域在预测期内复合年复合成长率将超过 14.2%。

目录

第1章调查方法与范围

第2章执行摘要

第3章预防性医疗技术和服务市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 预防保健技术与服务市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章预防保健技术与服务市场：类型估计与趋势分析

  • 预防保健技术与服务市场：重点
  • 预防性医疗技术和服务市场：2022 年和 2030 年趋势和市场占有率分析
  • 早期检测与筛检技术
  • 慢性病管理技术
  • 疫苗
  • 先进技术减少错误

第5章预防性医疗技术与服务市场：区域估计与趋势分析

  • 区域展望
  • 按地区分列的预防性医疗技术和服务市场：要点
  • 北美洲
    • 2018-2030 年北美市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018 年至 2030 年 MEA 市场估计与预测
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第6章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Myriad Genetics, Inc.
    • Quest Diagnostics Incorporated
    • Medtronic
    • Abbott
    • Merck & Co., Inc.
    • GSK plc
    • Omnicell
    • MCKESSON CORPORATION
Product Code: GVR-1-68038-103-0

Preventive Healthcare Technologies And Services Market Growth & Trends:

The global preventive healthcare technologies and services market size is expected to reach USD 585.6 billion by 2030, registering a CAGR of 11.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Key factors driving the market expansion include the growing awareness about preventive measures, which enhance the quality of life, lifespan, and minimize the possible healthcare spending.

The growth of this market is attributed to the adoption of advanced technology and the development of preventive measures, including vaccines, screening & monitoring devices, and smart devices to reduce medical errors. Growth of the market is also fueled by factors such as reducing the birth rate that is resulting in an increase of the geriatric population, which is more prone to chronic diseases.

With the introduction of the Human Development Index (HDI) ratings since 2010, all countries are engaged in the overall development of their country and citizens. Life expectancy has a significant impact on HDI calculations. Governments of the countries have been focusing on improving life expectancy of the people by implementing various programs, including free or affordable vaccination, smoking cessation, and affordable insurance schemes. These programs cause a direct positive impact on preventable technologies and services space.

A large share of preventive healthcare includes early detection and screening technology. This segment pertains to personalized diagnostic techniques, which has captured the largest share owing to the accuracy and availability of the innovative techniques for diagnosis.

Preventive Healthcare Technologies And Services Market Report Highlights:

  • According to data published by the WHO, the percentage of the total vaccinations in the U.S. has been growing. The vaccinations included those funded by the government as well as private purchases.
  • In 2022, the early detection and screening technologies' segment captured the largest share. The advantages associated with personalized medicine technologies, such as high accuracy and detection of the possible disease or disorder at an early stage, are mainly attributed to the largest share of the segment.
  • With the introduction of advanced technology and the growing demand for accurate screening methods, the growth of early detection and screening is expected to be the fastest during the forecast period.
  • North America dominated the market with the largest revenue share of 40.4% in 2022.
  • Growing economies and government initiatives are expected to drive the growth of the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 14.2% during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Preventive Healthcare Technologies & Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Preventive Healthcare Technologies & Services Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Preventive Healthcare Technologies & Services Market: Type Estimates & Trend Analysis

  • 4.1. Preventive Healthcare Technologies & Services Market: Key Takeaways
  • 4.2. Preventive Healthcare Technologies & Services Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Early Detection & Screening Technologies
    • 4.3.1. Early detection & screening technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.2. Automated screening
      • 4.3.2.1. Automated screening market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.3. Personalized medicine
      • 4.3.3.1. Personalized medicine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.3.4. Other advanced screening technologies
      • 4.3.4.1. Other advanced screening technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.4. Chronic Disease Management Technologies
    • 4.4.1. Chronic disease management technologies market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.2. Blood pressure monitors
      • 4.4.2.1. Blood pressure monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.3. Asthma monitors
      • 4.4.3.1. Asthma monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.4. Cardiovascular monitors
      • 4.4.4.1. Cardiovascular monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.4.5. Glucose monitors
      • 4.4.5.1. Glucose monitors market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.5. Vaccines
    • 4.5.1. Vaccines market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.2. Infectious diseases
      • 4.5.2.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.3. Cancer vaccine
      • 4.5.3.1. Cancer vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.4. Autism vaccine
      • 4.5.4.1. Autism vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.5. Allergy vaccine
      • 4.5.5.1. Allergy vaccine market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.5.6. Other new vaccines
      • 4.5.6.1. Other new vaccines market estimates and forecasts, 2018 to 2030 (USD Billion)
  • 4.6. Advanced Technologies to Reduce Errors
    • 4.6.1. Advanced technologies to reduce errors market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.2. Electronic prescribing
      • 4.6.2.1. Electronic prescribing market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.3. Clinical decision support system
      • 4.6.3.1. Clinical decision support system market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.4. Smart infusion pumps
      • 4.6.4.1. Smart infusion pumps market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.5. Computerized provider order entry system
      • 4.6.5.1. Computerized provider order entry system market estimates and forecasts, 2018 to 2030 (USD Billion)
    • 4.6.6. Smart packaging
      • 4.6.6.1. Smart packaging market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. Preventive Healthcare Technologies & Services Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Preventive Healthcare Technologies & Services Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. UK
      • 5.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. France
      • 5.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Norway
      • 5.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.9. Denmark
      • 5.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. China
      • 5.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. India
      • 5.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Mexico
      • 5.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.4. Argentina
      • 5.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. South Africa
      • 5.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. UAE
      • 5.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Myriad Genetics, Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Quest Diagnostics Incorporated
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Medtronic
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Abbott
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Merck & Co., Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. GSK plc
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Omnicell
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. MCKESSON CORPORATION
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 3 North America preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 4 U.S. preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 5 Canada preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 6 Europe preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 7 Europe preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 8 Germany preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 9 UK preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 10 France preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 11 Italy preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 12 Spain preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 13 Sweden preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 14 Norway preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 15 Denmark preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 16 Asia Pacific preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 17 Asia Pacific preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 18 China preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 19 Japan preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 20 India preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 21 Australia preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 22 Thailand preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 23 South Korea preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 24 Latin America preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 25 Latin America preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 26 Brazil preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 27 Mexico preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 28 Argentina preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 29 Middle East and Africa preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 30 Middle East and Africa preventive healthcare technologies and services market, by region, 2018 - 2030 (USD Billion)
  • Table 31 South Africa preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 32 Saudi Arabia preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 33 UAE preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)
  • Table 34 Kuwait preventive healthcare technologies and services market, by type, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Preventive healthcare technologies and services: market outlook
  • Fig. 9 Preventive healthcare technologies and services competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Preventive healthcare technologies and services market driver impact
  • Fig. 15 Preventive healthcare technologies and services market restraint impact
  • Fig. 16 Preventive healthcare technologies and services market strategic initiatives analysis
  • Fig. 17 Preventive healthcare technologies and services market: Type movement analysis
  • Fig. 18 Preventive healthcare technologies and services market: Type outlook and key takeaways
  • Fig. 19 Early detection & screening technologies market estimates and forecasts, (USD Billion) 2018 - 2030
  • Fig. 20 Automated screening market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Personalized medicine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Other advanced screening technologies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Chronic disease management technologies market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Blood pressure monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Asthma monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Cardiovascular monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Glucose monitors market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Vaccines market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Infectious diseases vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Cancer vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Autism vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Allergy vaccine market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Other new vaccines market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Advanced technologies to reduce error market estimates and forecasts, (USD Billion) 2018 - 2030
  • Fig. 35 Electronic prescribing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Clinical decision supports system market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Smart infusion pumps market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Computerized provider order entry system market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Smart packaging and automated prescription formulation and dispensing market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Preventive healthcare technologies and services market: Regional movement analysis
  • Fig. 41 Preventive healthcare technologies and services market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)